Although a few studies have explored the association between human BTN3 molecules and ovarian cancer [89,92,168], recently Lebrero-Fernández et al. has been able to clarify the connection between BTN/BTNL molecules and control of the T-lymphocyte-based immune responses, which are genetically associated with the inflammatory disorders and cancer [87]. The gene discussed is BTNL9; the disease is cancer.